New use of angiotensin II antagonists

Details for Australian Patent Application No. 2001274765 (hide)

Owner AstraZeneca AB

Inventors Schrader, Harald

Agent Davies Collison Cave

Pub. Number AU-B-2001274765

PCT Pub. Number WO01/97807

Priority 0002353 22.06.00 SE

Filing date 15 June 2001

Wipo publication date 2 January 2002

Acceptance publication date 18 August 2005

International Classifications

A61K 031/4184

A61P 025/06 Drugs for disorders of the nervous system

A61P 009/12 Drugs for disorders of the cardiovascular system

A61K 031/519 - ortho- or peri-condensed with heterocyclic rings

A61K 031/506 - not condensed and containing further heterocyclic rings

A61K 031/437

A61K 031/4196 - 1,2,4-Triazoles

A61K 031/4188

A61K 031/4178

Event Publications

18 August 2005 Application Accepted

  Published as AU-B-2001274765

15 December 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001274766-New formulation comprising a betablocker and optionally a cholesterol-lowering agent

2001274764-Novel compounds